Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Tempest Therapeutics, Inc. TPST

Full chart Compare
Set alert

Price alert · TPST

All alert types
0.38 USD -0.08 (-18.20%)

At closeNov 6, 2026, 5:05 AM EST

0.39 +0.01 +3.92%

Pre-market · Nov 6, 5:05 AM ET

0.3706 Day range 0.4799
0.3706 52-week range 10.33
YTD
-86.93%
1 year
-96.07%

Financial health

Altman Z-Score

-53.80 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.5×
FY 2016: -7.8×FY 2017: -0.1×FY 2018: -5.9×FY 2019: -26.9×FY 2020: -0.7×FY 2021: -8.8×FY 2022: -4.7×FY 2023: -29.9×FY 2024: -7.2×FY 2025: -0.5×
FY 2016 5y median -7.2× FY 2025
P/S 0.0×
FY 2016: 979×FY 2017: 16.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.8×
FY 2016: 5.9×FY 2017: 2.1×FY 2018: 2.3×FY 2019: 20.5×FY 2020: -0.2×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 32.9×FY 2024: 15.8×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
P/FCF -0.4×
FY 2016: -9.9×FY 2017: -0.2×FY 2018: -6.8×FY 2019: -28.9×FY 2020: -0.7×FY 2021: -0.8×FY 2022: -0.4×FY 2023: -32.0×FY 2024: -9.0×FY 2025: -0.4×
FY 2016 5y median -0.8× FY 2025
EV/EBITDA -0.5×
FY 2016: -7.5×FY 2017: 0.1×FY 2018: -3.2×FY 2019: -26.2×FY 2020: 0.2×FY 2021: 0.5×FY 2022: -0.1×FY 2023: -31.2×FY 2024: -7.2×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
EV/Sales 0.0×
FY 2016: 911×FY 2017: -34.4×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -225.2%
FY 2016: -10.1%FY 2017: -425.6%FY 2018: -14.8%FY 2019: -3.5%FY 2020: -146.4%FY 2021: -130.6%FY 2022: -238.3%FY 2023: -3.1%FY 2024: -11.1%FY 2025: -225.2%
FY 2016 5y median -130.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -727.1%FY 2017: 90.5%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -12406.1%FY 2017: -6943.1%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -12597.2%FY 2017: -28670.5%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -393.9%
FY 2016: -76.0%FY 2017: -3796.1%FY 2018: -38.3%FY 2019: -76.1%FY 2020: 27.8%FY 2021: -78.4%FY 2022: -197.2%FY 2023: -110.2%FY 2024: -218.8%FY 2025: -393.9%
FY 2016 5y median -197.2% FY 2025
ROIC -179.5%
FY 2016: -74.1%FY 2017: -128.9%FY 2018: -30.9%FY 2019: -70.5%FY 2020: -94.8%FY 2021: -49.4%FY 2022: -86.1%FY 2023: -61.5%FY 2024: -121.8%FY 2025: -179.5%
FY 2016 5y median -86.1% FY 2025
ROA -155.1%
FY 2016: -67.1%FY 2017: -426.9%FY 2018: -32.3%FY 2019: -59.4%FY 2020: -83.6%FY 2021: -38.6%FY 2022: -77.5%FY 2023: -57.1%FY 2024: -100.9%FY 2025: -155.1%
FY 2016 5y median -77.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 135.7%FY 2017: -54.8%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 36.8%
FY 2016: -12.5%FY 2017: 74.7%FY 2018: -12.9%FY 2019: -96.4%FY 2020: 57.5%FY 2021: -39.8%FY 2022: -28.4%FY 2023: 15.8%FY 2024: -44.1%FY 2025: 36.8%
FY 2016 FY 2025
EPS (diluted) -322.0%
FY 2016: 5.3%FY 2017: -12476.4%FY 2018: 99.6%FY 2019: 81.5%FY 2020: -1156.0%FY 2021: 98.7%FY 2022: 59.2%FY 2023: 39.9%FY 2024: 21.5%FY 2025: -322.0%
FY 2016 FY 2025
Free Cash Flow 19.8%
FY 2016: -15.9%FY 2017: 68.4%FY 2018: -16.4%FY 2019: -75.7%FY 2020: 54.2%FY 2021: -36.8%FY 2022: -21.2%FY 2023: 13.0%FY 2024: -21.6%FY 2025: 19.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 8.8×FY 2017: 4.8×FY 2018: 8.5×FY 2019: 5.7×FY 2020: 6.2×FY 2021: 3.4×FY 2022: 4.5×FY 2023: 4.3×FY 2024: 2.2×FY 2025: 2.5×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 2.5×
FY 2016: 8.8×FY 2017: 4.8×FY 2018: 8.5×FY 2019: 5.7×FY 2020: 6.2×FY 2021: 3.4×FY 2022: 4.5×FY 2023: 4.3×FY 2024: 2.2×FY 2025: 2.5×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 1.2×
FY 2016: 0.0×FY 2017: 0.3×FY 2018: 0.0×FY 2019: 0.1×FY 2020: -0.0×FY 2021: 0.5×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 0.8×FY 2025: 1.2×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 0.6×FY 2017: 0.2×FY 2018: 2.7×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 1.2×FY 2022: 0.3×FY 2023: 0.7×FY 2024: 0.4×FY 2025: -0.0×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -128×
FY 2016: -123×FY 2017: 0.0×FY 2018: -173×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -21.0×FY 2022: -21.4×FY 2023: -20.1×FY 2024: -31.9×FY 2025: -128×
FY 2016 5y median -21.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31